Compound 228
Identifiers
- Canonical SMILES:
COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1ccc(cc1)-c1ccccc1
- InChi:
InChI=1S/C43H47N5O6S2/c1-46(2)27-24-36(31-55-38-12-8-5-9-13-38)44-40-23-22-39(30-41(40)48(50)51)56(52,53)45-42(49)34-16-20-37(21-17-34)47-28-25-43(54-3,26-29-47)35-18-14-33(15-19-35)32-10-6-4-7-11-32/h4-23,30,36,44H,24-29,31H2,1-3H3,(H,45,49)/t36-/m1/s1
- InChiKey:
DFMAYBTXVMUNDL-PSXMRANNSA-N
External links
168318269 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 9.05 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 793.30 g/mol | |||
HBA | 11 | |||
HBD | 2 | |||
HBA + HBD | 13 | |||
AlogP | 6.82 | |||
TPSA | 136.80 | |||
RB | 15 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
17256834 | 8n | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 9.00 | |
17256834 | 8n | B2CL1 Q07817 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 9.05 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5353 | Navitoclax | DB12340 | |
0.4783 | Venetoclax | DB11581 | |
0.4663 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
0.4336 | 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid | DB02449 | |
0.4059 | Repinotan | DB06506 | |
0.4039 | Zafirlukast | DB00549 | |
0.4016 | Omidenepag isopropyl | DB15071 | |
0.4011 | Sulfabenzamide | DB09355 | |
0.3966 | VX-659 | DB15177 | |
0.3957 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.3944 | Pipotiazine | DB01621 | |
0.3942 | SC-74020 | DB01630 | |
0.3937 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.3885 | Elismetrep | DB15287 | |
0.3816 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DB04394 |